| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Erlotinib | CCLE | pan-cancer | AAC | -0.0017 | 1 |
| mRNA | SCH-79797 | CTRPv2 | pan-cancer | AAC | 0.0013 | 1 |
| mRNA | QL-VIII-58 | GDSC1000 | pan-cancer | AAC | 0.0016 | 1 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | SKI-II | CTRPv2 | pan-cancer | AAC | -0.0012 | 1 |
| mRNA | XMD14-99 | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | 0.0011 | 1 |
| mRNA | ML334 diastereomer | CTRPv2 | pan-cancer | AAC | -0.0014 | 1 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | 0.00095 | 1 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.0015 | 1 |